Overview
Novartis Poland is part of a global healthcare company that works with patients, caregivers and healthcare professionals to improve and extend human life. The company supports knowledge exchange, education and therapy development, while pursuing environmental and social responsibility and building a diverse team serving more than 766 million patients worldwide.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1993-07-05. Active
31 1600 1127 1847 1458 5000 0003- 58 1600 1127 1847 1458 5000 0002
- 85 1600 1127 1847 1458 5000 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 22, 2025 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
12 tenders recorded as contractor, with a total value of $84,644,222.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Feb 24, 2026 | Dostawa produktów leczniczych Programy lekowe w ramach terapii CAR-T | $23.6M$23,614,263 | Uniwersytecki Szpital Kliniczny w Poznaniu | |
| Oct 1, 2025 | „Dostawa leków, preparatów farmaceutycznych, leków onkologicznych, wyrobów medycznych, materiałów opatrunkowych, materiałów szewnych, kontrastów i innych.” | $4.2M$4,179,660 | Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy | |
| Sep 2, 2025 | Produkt leczniczy - Tisagenlecleucelum | $3.4M$3,449,925 | Instytut Hematologii i Transfuzjologii |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The following are authorized to submit declarations of will within the scope of rights and obligations and to sign documents on behalf of the company: each member of the management board independently or an individual commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Novartis Pharma Ag | 44,183 | $11,934,900.05 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Yu Tian (44)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Emiliano Zavagli (37)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NeucaS.A. | $3,426,322,199.90 | inwestor.neuca.pl | ||
| Polska Grupa FarmaceutycznaS.A. | $1,778,266,449.02 | pgf.com.pl | ||
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| Bayersp. z o.o. | $624,313,880.67 | bayer.pl | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| A.P.N. PromiseS.A. | $339,856,045.54 | apnpromise.pl | ||
| NovoS.A. | $209,522,261.96 | novo-sa.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Exclusive Networks PolandS.A. | $150,510,045.90 | exclusive-networks.com | ||
| NettleS.A. | $85,124,937.06 | nettle.pl |
Change history
| Date | Event | |
|---|---|---|
| 2010-12-20 | Address change (Al.wincentego Witosa 31, 00-710, Warszawa → Marynarska 15, 02-674, Warszawa) | |
| 2004-02-16 | Share capital change (44,182,900.00 PLN → 44,183,000.00 PLN) | |
| 2001-10-31 | Entered in the register |
FAQ
Last updated: 2026-10-02